www.rxcanadapharmacy.net
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Carvedilol - Coreg, Trandate, Volmax Cr
Generic Coreg
Carvedilol 3.125/6.25/12.5/25mg
Treating high blood pressure or certain types of heart failure.
$0.62
Buy now!
Generic Trandate
Generic Trandate is an alpha- and beta-blocker used to treat high blood pressure. It may be used alone or in combination with other medicines, such as diuretics.
$0.58
Buy now!
Generic Volmax Cr
Generic Volmax CR is used to treat bronchospasm (wheezing, shortness of breath) associated with reversible obstructive airway disease such as asthma.
$0.51
Buy now!
Choose Your language:
- Testimonials
-
Thank you VERY much for your kind email, which explains everything. And for your continued good service, which has - frankly - saved my relationship with the woman I love.
Read more »
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- New URMC trial to evaluate carvedilol for high blood pressure - News-Medical.net
- New URMC trial to evaluate carvedilol for high blood pressureNews-Medical
- Dollars and Sense, Baby and Bathwater: The Case for CAM Research - Huffington Post
- Dollars and Sense, Baby and Bathwater: The Case for CAM ResearchHuffington PostAs an example, in 2001 a paper was published in The Lancet demonstrating the benefits of a drug called carvedilol in heart failure
- Common Blood Pressure Drugs May Not Cut Colon Cancer Risk - U.S. News & World Report
- U
- Contrary to popular belief, beta-blockers don't prevent colorectal cancer - Los Angeles Times
- Contrary to popular belief, beta-blockers don't prevent colorectal cancerLos Angeles TimesAmong the best known are atenolol (Tenormin), bisoprolol (Zebeta), metoprolol (Lopresor or Toprol) and carvedilol (Coreg)
- URMC research team wins $1.9 million grant - Rochester Business Journal
- URMC research team wins $1
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
